Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CASI Pharmaceuticals (CASI) Current Taxes (2021 - 2023)

Historic Current Taxes for Pharmaceuticals (CASI) over the last 3 years, with Q4 2023 value amounting to $481000.0.

  • Pharmaceuticals' Current Taxes fell 7468.42% to $481000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $481000.0, marking a year-over-year decrease of 7468.42%. This contributed to the annual value of $481000.0 for FY2023, which is 7468.42% down from last year.
  • Per Pharmaceuticals' latest filing, its Current Taxes stood at $481000.0 for Q4 2023, which was down 7468.42% from $1.9 million recorded in Q4 2022.
  • Over the past 5 years, Pharmaceuticals' Current Taxes peaked at $1.9 million during Q4 2022, and registered a low of $481000.0 during Q4 2023.
  • Over the past 3 years, Pharmaceuticals' median Current Taxes value was $652000.0 (recorded in 2021), while the average stood at $1.0 million.
  • Its Current Taxes has fluctuated over the past 5 years, first soared by 19141.1% in 2022, then plummeted by 7468.42% in 2023.
  • Over the past 3 years, Pharmaceuticals' Current Taxes (Quarter) stood at $652000.0 in 2021, then skyrocketed by 191.41% to $1.9 million in 2022, then plummeted by 74.68% to $481000.0 in 2023.
  • Its last three reported values are $481000.0 in Q4 2023, $1.9 million for Q4 2022, and $652000.0 during Q4 2021.